Barclays Starts Progyny (PGNY) at Overweight
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 11/4/2026
- Wall Street rallies after Democrats win Congress; data center stocks slide
- What the Democratic sweep in the midterms means for markets
- SpaceX, Tesla slide as election risks mount, Morgan Stanley turns bullish
- CVS Health plans to split into two public companies by 2028
- AI sector outlook darkens as Democrat wins threaten $900B capex cycle
Tweet
Share
E-mailGet Alerts PGNY Hot Sheet
Price: $30.57 +5.20%
Rating Summary:
12 Buy, 4 Hold, 0 Sell
Rating Trend:
Down
Today's Overall Ratings:
Up: 15 | Down: 24 | New: 12
Rating Summary:
12 Buy, 4 Hold, 0 Sell
Rating Trend:
Down
Today's Overall Ratings:
Up: 15 | Down: 24 | New: 12
Join SI Premium – FREE
Barclays analyst Glen Santangelo initiates coverage on Progyny (NASDAQ: PGNY) with a Overweight rating and a price target of $29.00.
For an analyst ratings summary and ratings history on Progyny click here. For more ratings news on Progyny click here.
Shares of Progyny closed at $24.02 yesterday.
You May Also Be Interested In
- H.C. Wainwright Assumes MiNK Therapeutics (INKT) at Buy
- Jefferies Starts Aura Consolidated Group (AXQ:AU) at Hold
- Bernstein SocGen Group Starts GlaxoSmithKline Pharmaceuticals (GLXO:IN) at Outperform
Create E-mail Alert Related Categories
New CoverageSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
